Simonetta Masieri

Pubblicazioni

Titolo Pubblicato in Anno
Pre-biologic FeNO might predict anti-IL-5/IL-5Rα response to treatment in severe asthmatics THE JOURNAL OF ASTHMA 2025
Narrative review of genetic and immunological mechanisms involved in the pathogenesis of Kimura’s disease: new therapeutic targets GENES 2025
Pilot study on the efficacy of a novel questionnaire for assessing psychological health in patients with chronic rhinosinusitis with nasal polyps treated with biologics HEALTHCARE 2025
Long-term perspectives on chronic rhinosinusitis with nasal polyps: evaluating recurrence rates after functional endoscopic sinus surgery in the biologics era—a 5-year follow-up study JOURNAL OF PERSONALIZED MEDICINE 2024
Real-life evidence of Mepolizumab treatment in chronic rhinosinusitis with nasal polyps: a multicentric study JOURNAL OF CLINICAL MEDICINE 2024
Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY AND HEAD & NECK 2024
Allergic rhinitis in professional singers: a monoinstitutional series JOURNAL OF VOICE 2024
Real-world effectiveness of dupilumab in a european cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2024
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps): a multicentric observational phase IV real‐life study (DUPIREAL) ALLERGY 2023
Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics ACTA OTORHINOLARYNGOLOGICA ITALICA 2023
Dupilumab’s impact on blood parameters in nasal polyposis: 18-month follow-up in real life JOURNAL OF IMMUNOLOGY RESEARCH 2023
The impact of antibiotics and steroids on the nasal microbiome in patients with chronic rhinosinusitis: a systematic review according to PICO criteria JOURNAL OF PERSONALIZED MEDICINE 2023
Long-term subjective and objective assessment of smell and taste in COVID-19 CELLS 2022
Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 2022
Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a pilot real-life study IMMUNOLOGY LETTERS 2022
Effects of the silica dust on the nasal mucosa of ceramic workers SUSTAINABILITY 2022
Chronic rhinosinusitis outcome registry (CHRINOSOR): establishment of an international outcome registry driven by mHealth technology JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE 2022
The safety of sublingual immunotherapy, can the rare systemic reactions be prevented? EXPERT OPINION ON DRUG SAFETY 2021
VEGF/VEGFRs nasal expression is reduced by Mepolizumab in chronic rhinosinusitis with nasal polyposis ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 2021
Diagnostic performance of nasal cytology EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma